
Company valuation, historical trends, and peer comparisons.
According to IDEAYA Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.79B. This represents a change of -0.03% compared to the average of 2.79B of the last 4 quarters.
The mean historical Enterprise Value of IDEAYA Biosciences, Inc. over the last ten years is 1.00B. The current 2.79B Enterprise Value has changed 177.75% with respect to the historical average. Over the past ten years (40 quarters), IDYA's Enterprise Value was at its highest in in the June 2026 quarter at 3.19B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
1.00B
Median
687.90M
Minimum
124.46M
Maximum
2.97B
Discovering the peaks and valleys of IDEAYA Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 175.10%
Maximum Annual Enterprise Value = 2.97B
Minimum Annual Increase = -11.34%
Minimum Annual Enterprise Value = 124.46M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 2.97B | 46.22% |
| 2024 | 2.03B | 7.48% |
| 2023 | 1.89B | 175.10% |
| 2022 | 687.90M | -7.85% |
| 2021 | 746.50M | 165.86% |
| 2020 | 280.79M | 125.62% |
| 2019 | 124.46M | -10.37% |
| 2018 | 138.85M | -11.34% |
The current Enterprise Value of IDEAYA Biosciences, Inc. (IDYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.30B
5-year avg
1.67B
10-year avg
1.00B
IDEAYA Biosciences, Inc.’s Enterprise Value is less than Tango Therapeutics, Inc. (3.51B), greater than Prelude Therapeutics Incorporated (152.52M), greater than Verastem, Inc. (829.16M), less than Erasca, Inc. (4.95B), greater than Nurix Therapeutics, Inc. (2.17B), greater than Foghorn Therapeutics Inc. (96.13M), less than Revolution Medicines, Inc. (40.51B), less than Cogent Biosciences, Inc. (5.31B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.51B | $3.83B | |
| 152.52M | $222.26M | |
| 829.16M | $881.18M | |
| 4.95B | $4.95B | |
| 2.17B | $2.83B | |
| 96.13M | $121.10M | |
| 40.51B | $40.69B | |
| 5.31B | $5.25B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IDEAYA Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IDEAYA Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is IDEAYA Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for IDEAYA Biosciences, Inc. (IDYA)?
What is the 3-year average Enterprise Value for IDEAYA Biosciences, Inc. (IDYA)?
What is the 5-year average Enterprise Value for IDEAYA Biosciences, Inc. (IDYA)?
How does the current Enterprise Value for IDEAYA Biosciences, Inc. (IDYA) compare to its historical average?